US › Healthcare

MIRA Pharmaceuticals, Inc. Common Stock (MIRA)

US · Healthcare · Drug Manufacturers - General

$0.76+5.52%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.2M

EPS

$-0.03

Key statistics

Market cap

$32.5M

Forward P/E

0.0

P/B

4.06

Book value

$0.19

EPS (TTM)

$-1.22

52-week high

$2.45

52-week low

$0.60

50-day MA

$0.82

200-day MA

$1.10

Beta

1.53

Analyst view

Analysts rate MIRA Pharmaceuticals, Inc. Common Stock a hold (0 buy, 1 hold, 0 sell out of 1) with an average price target of $17.75.

Shareholding

Insiders

30.58%

Institutions

5.42%

Largest institutional holders

Fund	Stake
Vanguard Capital Management, LLC	1.65%
Cross Staff Investments Inc	0.86%
Geode Capital Management, LLC	0.69%
Vanguard Fiduciary Trust Co	0.40%
BlackRock Inc	0.27%
Northern Trust Corp	0.16%
First American Bank/Carpentersville IL	0.14%
Commonwealth Equity Services, LLC	0.13%

See the full picture

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for MIRA Pharmaceuticals, Inc. Common Stock — free to start.

Google Play App Store

Other Healthcare companies

Eli Lilly and Company Johnson & Johnson AbbVie Inc Merck & Company Inc UnitedHealth Group Incorporated Novartis AG ADR AstraZeneca PLC Thermo Fisher Scientific Inc Amgen Inc Novo Nordisk A/S Gilead Sciences Inc Abbott Laboratories

Data updated 2026-09-18.